Drugs / rsPSMA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00705835 | Jan 2003 → Jan 2008 | prostate cancer | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rs-PSMA | “Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA)” NCT00705835 ↗ |
| Known as | Recombinant Soluble Prostate-Specific Membrane Antigen | “Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA)” NCT00705835 ↗ |
| Modality | Protein / enzyme biologic | “rsPSMA protein” NCT00705835 ↗ |